Enhanced Housing Placement Assistance

Overview

Randomized controlled trial of housing placement assistance for homeless persons with HIV

Full Title of Study: “An Enhanced Housing Placement Assistance (EHPA) Program for Homeless Persons Living With HIV/AIDS in New York City”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Health Services Research
    • Masking: None (Open Label)
  • Study Primary Completion Date: July 31, 2017

Detailed Description

Approximately 800 persons living with HIV/AIDS (PLWHA) reside in HIV emergency single-room-occupancy (SRO) hotels in New York City and do not have the ability to secure permanent housing on their own. The study evaluated a pilot program which fast-tracked PLWHA from HIV emergency SRO hotels into permanent housing. The Enhanced Housing Placement Assistance (EHPA) program had three components: 1) active recruitment of emergency SRO hotel residents with high need for housing; 2) assistance in the rapid (fast-track) acquisition of permanent housing; and 3) participation in a 12-month support services program designed to prevent PLWHA from relapsing into homelessness, with services focused on increasing clients' capacity to live independently and maintain housing stability. Participants were randomly assigned to either 1) EHPA or 2) usual care, which included standard connections to services and housing programs offered by the New York City HIV/AIDS Services Administration (HASA), Housing Opportunities for Persons With AIDS (HOPWA), or Ryan White services, and were followed over twelve months using a questionnaire developed with significant input from the target population of PLWHA residing in emergency SRO hotels.

Interventions

  • Other: Enhanced housing placement assistance
    • assistance in the rapid (fast-track) acquisition of permanent housing; and participation in a 12-month support services program designed to prevent PLWHA from relapsing into homelessness, with services focused on increasing clients’ capacity to live independently and maintain housing stability
  • Other: Standard housing placement assistance
    • standard connections to services and housing programs offered by HASA, HOPWA, or Ryan White

Arms, Groups and Cohorts

  • Experimental: Enhanced housing placement assistance
  • Active Comparator: Standard housing placement assistance

Clinical Trial Outcome Measures

Primary Measures

  • Number of Participants With Placement in Permanent Housing
    • Time Frame: 12 months post-enrollment
    • supportive housing, rental assistance, other non-emergency housing, etc.

Secondary Measures

  • Number of Participants With Engagement in HIV Care
    • Time Frame: 12 months post-enrollment
    • any reported HIV viral load (VL) or CD4 test
  • Number of Participants With HIV Viral Suppression
    • Time Frame: 12 months post-enrollment
    • Last viral load is under 200 copies/mL

Participating in This Clinical Trial

Inclusion Criteria

  • Person living with HIV in New York City – Residing in an New York City HASA single-adult single-room-occupancy (SRO) hotel Exclusion Criteria:

  • Inability to provide informed consent – Inability to complete survey in English or Spanish

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • New York City Department of Health and Mental Hygiene
  • Provider of Information About this Clinical Study
    • Principal Investigator: Ellen Wiewel, Director of Research and Evaluation – New York City Department of Health and Mental Hygiene
  • Overall Official(s)
    • Ellen W Wiewel, DrPH, Principal Investigator, New York City Department of Health and Mental Hygiene
    • Vivian L Towe, PhD, Principal Investigator, RAND

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.